Literature DB >> 12880289

A mechanistic and kinetic study of the E-ring hydrolysis and lactonization of a novel phosphoryloxymethyl prodrug of camptothecin.

Bradley A Hanson1, Richard L Schowen, Valentino J Stella.   

Abstract

PURPOSE: This study was done to determine the E-ring hydrolysis and lactonization mechanism of a water-soluble 20-phosphoryloxymethyl (POM) prodrug of camptothecin (P-CPT). Specifically, the role of the phosphate group in facilitating E-ring hydrolysis was examined.
METHODS: Resolution between the lactone and carboxylate forms of P-CPT and camptothecin (CPT) was achieved with a RPHPLC assay using UV-visible detection. E-ring P-CPT hydrolysis and lactonization kinetics were followed using 20 mM acetate or phosphate buffer (micro = 0.15 NaCl) over the pH range of 4 to 8 at 25.0 degrees C. A kinetic solvent isotope effect (KSIE) study was used to further probe the mechanism of E-ring hydrolysis.
RESULTS: The hydrolysis and lactonization reactions followed pseudo-first-order kinetics in the approach to equilibrium. The equilibrium ratio of the open and closed forms of P-CPT was dependent on pH, with the closed form dominant at low pH and the open form dominant at high pH. Buffer concentration changes had little to no effect on the rate of P-CPT E-ring hydrolysis. The KSIE study provided an overall isotope effect of 2.47 and a proton inventory KSIE consistent with an intramolecular general base catalysis.
CONCLUSIONS: P-CPT has a pH-dependent equilibrium between the lactone and carboxylate forms similar but not identical to that of CPT. The results suggest a hydrolysis reaction mechanism that involves a single site hydrogen exchange facilitated intramolecularly by the dianionic phosphate moiety of P-CPT via either general base catalysis of the lactone ring attack by water or breakdown of the tetrahedral intermediate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880289     DOI: 10.1023/a:1024410322870

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  27 in total

1.  Plant antitumor agents. 29. Synthesis and biological activity of ring D and ring E modified analogues of camptothecin.

Authors:  A W Nicholas; M C Wani; G Manikumar; M E Wall; K W Kohn; Y Pommier
Journal:  J Med Chem       Date:  1990-03       Impact factor: 7.446

2.  Hydrolysis of D-glucono-delta-lactone. I. General acid-base catalysis, solvent deuterium isotope effects, and transition state characterization.

Authors:  Y Pocker; E Green
Journal:  J Am Chem Soc       Date:  1973-01-10       Impact factor: 15.419

3.  Plasma camptothecin (NSC-100880) levels during a 5-day course of treatment: relation to dose and toxicity.

Authors:  P J Creaven; L M Allen; F M Muggia
Journal:  Cancer Chemother Rep       Date:  1972-10

Review 4.  Solvent isotope effects of enzyme systems.

Authors:  K B Schowen; R L Schowen
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

5.  Novel prodrug approach for tertiary amines: synthesis and preliminary evaluation of N-phosphonooxymethyl prodrugs.

Authors:  J P Krise; J Zygmunt; G I Georg; V J Stella
Journal:  J Med Chem       Date:  1999-08-12       Impact factor: 7.446

6.  Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.

Authors:  R P Hertzberg; M J Caranfa; K G Holden; D R Jakas; G Gallagher; M R Mattern; S M Mong; J O Bartus; R K Johnson; W D Kingsbury
Journal:  J Med Chem       Date:  1989-03       Impact factor: 7.446

7.  A novel prodrug approach for tertiary amines. 2. Physicochemical and in vitro enzymatic evaluation of selected N-phosphonooxymethyl prodrugs.

Authors:  J P Krise; S Narisawa; V J Stella
Journal:  J Pharm Sci       Date:  1999-09       Impact factor: 3.534

8.  On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex.

Authors:  R P Hertzberg; M J Caranfa; S M Hecht
Journal:  Biochemistry       Date:  1989-05-30       Impact factor: 3.162

9.  Plant antitumor agents. 25. Total synthesis and antileukemic activity of ring A substituted camptothecin analogues. Structure-activity correlations.

Authors:  M C Wani; A W Nicholas; G Manikumar; M E Wall
Journal:  J Med Chem       Date:  1987-10       Impact factor: 7.446

10.  Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.

Authors:  C Jaxel; G Capranico; D Kerrigan; K W Kohn; Y Pommier
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

View more
  2 in total

1.  Camptothecin nanocolloids based on N,N,N-trimethyl chitosan: efficient suppression of growth of multiple myeloma in a murine model.

Authors:  Zhengguang Li; Xingyi Li; Zhixing Cao; Youzhi Xu; Hongjun Lin; Yinglan Zhao; Yuquan Wei; Zhiyong Qian
Journal:  Oncol Rep       Date:  2012-01-12       Impact factor: 3.906

2.  Self-defensive nano-assemblies from camptothecin-based antitumor drugs.

Authors:  Si-Yong Qin; Meng-Yun Peng; Lei Rong; Bin Li; Shi-Bo Wang; Si-Xue Cheng; Ren-Xi Zhuo; Xian-Zheng Zhang
Journal:  Regen Biomater       Date:  2015-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.